Dexamethasone on absent end-diastolic flow in umbilical artery, in growth restricted fetuses from early-onset preeclamptic pregnancies and the perinatal outcome
Close
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
328 0
SM ISO690:2012
TICA, Oana Sorina, TICĂ, Andrei Adrian, COJOCARU, Doriana, GHEONEA, Mihaela, TICA, Irina, ALEXANDRU, Dragos Ovidiu, COJOCARU, Victor, PETCU, Lucian Cristian, TICA, Vlad Iustin. Dexamethasone on absent end-diastolic flow in umbilical artery, in growth restricted fetuses from early-onset preeclamptic pregnancies and the perinatal outcome. In: Annals of Medicine, 2021, nr. 1(53), pp. 1455-1463. ISSN 0785-3890. DOI: https://doi.org/10.1080/07853890.2021.1968030
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Annals of Medicine
Numărul 1(53) / 2021 / ISSN 0785-3890 /ISSNe 1651-2219

Dexamethasone on absent end-diastolic flow in umbilical artery, in growth restricted fetuses from early-onset preeclamptic pregnancies and the perinatal outcome

DOI:https://doi.org/10.1080/07853890.2021.1968030

Pag. 1455-1463

Tica Oana Sorina1, Tică Andrei Adrian1, Cojocaru Doriana23, Gheonea Mihaela14, Tica Irina5, Alexandru Dragos Ovidiu1, Cojocaru Victor2, Petcu Lucian Cristian5, Tica Vlad Iustin56
 
1 University of Medicine and Pharmacy Craiova,
2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
3 Timofei Moșneaga Republican Clinical Hospital,
4 Emergency Clinical County Hospital of Craiova,
5 Ovidius University, Constanța,
6 Regional Emergency Hospital of Constanta
 
 
Disponibil în IBN: 13 septembrie 2021


Rezumat

Background: Absent end-diastolic flow (AEDF) in the umbilical artery (UA) worsens the already poor prognosis of growth-restricted fetuses (GRFs) in pregnancies complicated by early-onset preeclampsia with severe features (ESP). Method: We assessed the correlation between the effect of maternal dexamethasone (Dex) on AEDF in the UA and perinatal outcomes, in 59 GRFs from EPS-complicated pregnancies. The maternal outcome was also evaluated. Results: The mean maternal age at inclusion was 22.4 ± 5.9 years. Dex transiently restored EDF in the UA in 38 (64.4%) cases (trAEDF group), but in 21 (35.6%) patients, the flow was persistently absent (prAEDF group). The effect lasted up to the 4th day. The gestational age at diagnosis, number of days from admission until delivery, and fetal weight were significantly lower in the prAEDF group than in the trAEDF group (p <.05). The same group had a significantly increased rate of fetal proximal deterioration, low APGAR scores, neonatal hypoxia, assisted ventilation, mild intraventricular haemorrhage (I/II), and respiratory distress syndrome, as well as maternal deterioration, especially in cases of resistant hypertension (p <.05). Although the rates of fetal acidemia and perinatal mortality in the prAEDF group were respectively three times and two times higher, the differences were not significant (p >.05). Conclusions: The Dex no-effect on UA Doppler in GRFs with AEDF in the UA, in EPS-complicated pregnancies, can be a useful marker for a higher risk of proximal fetal deterioration, poor state at delivery, neonatal hypoxic complications, and worsening maternal condition, but not for perinatal mortality. The findings also highlight the alarmingly younger age of patients with EPS. Finally, all these pregnancies should be monitored in a complex multidisciplinary manner in tertiary referral units.Key message The effect of dexamethasone on absent end-diastolic flow in the umbilical artery in growth-restricted fetuses from pregnancies complicated by early-onset preeclampsia with severe features can be a useful prognostic factor for perinatal outcomes.

Cuvinte-cheie
absent end-diastolic flow, dexamethasone, Early onset preeclampsia with severe features, growth restriction, perinatal outcome, umbilical artery